What is Cerus's cash & equivalents?

Cerus (CERS) reported cash & equivalents of $27.85M in Q1 2026.

How has Cerus's cash & equivalents changed year-over-year?

Cerus's cash & equivalents increased by 43.0% year-over-year, from $19.48M to $27.85M.

What is the long-term trend for Cerus's cash & equivalents?

Over 5 years (2020 to 2025), Cerus's cash & equivalents has grown at a -11.4% compound annual growth rate (CAGR), from $36.59M to $19.96M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Cerus CERS Cash & Equivalents

Cash & Equivalents at other companies

CorMedixCRMD

$179.08M+170%

HaemoneticsHAE

$245.44M-20.0%

Bio-Rad LaboratoriesBIO

$509M-2.7%

Protagonist TherapeuticsPTGX

$193.71M+38.7%

QuidelOrtho CorporationQDEL

$140.4M+10.4%

ADMA BiologicsADMA

$138.15M+92.9%

Other financials

Income statement

See full

Revenue$53.7M+24.1%

Operating income-$354.0K+94.0%

Net income-$1.6M+78.7%

EPS (diluted)-$0.01+75.0%

Balance sheet

See full

Total debt$45.0M-43.3%

Total equity$67.6M+21.7%

Total assets$222.9M+7.8%

Cash flow

See full

Operating cash flow-$3.0M-261%

CapEx$233.0K+108%

Free cash flow-$3.3M-243%

Valuation

See full

Market cap$573.06M+124%

Enterprise value$590.17M+86.7%

P/S2.9×-1.0×

Profitability

See full

Gross margin64%—

Operating margin-6.2%-2.1pp

Net margin-9.8%-2.8pp

FCF margin3.5%+1.9pp

Returns & leverage

See full

Return on equity-15.5%-5.6pp

Debt / equity0.7×-0.8×

Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cerus's cash & equivalents?: Cerus (CERS) reported cash & equivalents of $27.85M in Q1 2026.
How has Cerus's cash & equivalents changed year-over-year?: Cerus's cash & equivalents increased by 43.0% year-over-year, from $19.48M to $27.85M.
What is the long-term trend for Cerus's cash & equivalents?: Over 5 years (2020 to 2025), Cerus's cash & equivalents has grown at a -11.4% compound annual growth rate (CAGR), from $36.59M to $19.96M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.